Ketamine in the Treatment of Major Depressive Disorder

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.

Original languageEnglish (US)
Pages (from-to)228-231
Number of pages4
JournalJournal for Nurse Practitioners
Issue number3
StatePublished - Mar 2020


  • depression
  • ketamine
  • major depressive disorder (MDD)
  • mechanism of ketamine
  • psychiatric conditions
  • treatment of MDD

ASJC Scopus subject areas

  • Advanced and Specialized Nursing


Dive into the research topics of 'Ketamine in the Treatment of Major Depressive Disorder'. Together they form a unique fingerprint.

Cite this